Form 4: Zimmer Biomet Director Louis Shapiro Reports Acquisition of Phantom Stock Units

Director Louis Shapiro reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Summary

• On June 30, 2024, Louis Shapiro, a director of Zimmer Biomet Holdings, Inc., acquired 126.751 phantom stock units.
• These units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The conversion price is 1-for-1, and the units will be settled in shares of Company common stock within sixty days after Shapiro's service as a Director ends.
• Following the transaction, Shapiro beneficially owns 847.055 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns director interests with company performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.

Future Outlook

The phantom stock units will be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure related to director compensation and is common in publicly traded companies.

Stakeholder Impact

• The acquisition of phantom stock units aligns the director's interests with shareholders, potentially driving long-term value creation.

Key Dates